# German American Bancorp, Inc.: financial statements, quarterly

GABC · Nasdaq · CIK 714395 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gabc.md) · [Financials](/companies/gabc/financials.md) · [Filings](/companies/gabc/filings.md) · [Insiders](/companies/gabc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gabc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [84.1](/filings/0000714395-25-000021.md) | [90.5](/filings/0000714395-25-000031.md) | [88.5](/filings/0000714395-25-000053.md) | [90.7 d](/filings/0000714395-26-000011.md) | [111](/filings/0000714395-26-000027.md) | [123](/filings/0000714395-26-000032.md) | [127](/filings/0000714395-25-000053.md) | [127 d](/filings/0000714395-26-000011.md) | [123](/filings/0000714395-26-000027.md) | [127](/filings/0000714395-26-000032.md) |
| Interest expense | $m | [18.1](/filings/0000714395-23-000055.md) | [21.4 d](/filings/0000714395-24-000014.md) | [23.3](/filings/0000714395-24-000028.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [4.6](/filings/0000714395-24-000054.md) | [4.0 d](/filings/0000714395-26-000011.md) | [4.2](/filings/0000714395-25-000021.md) | [6.1](/filings/0000714395-25-000031.md) | [4.6](/filings/0000714395-25-000053.md) | [5.5 d](/filings/0000714395-26-000011.md) | [2.8](/filings/0000714395-26-000027.md) | [7.8](/filings/0000714395-26-000032.md) | [8.7](/filings/0000714395-25-000053.md) | [8.1 d](/filings/0000714395-26-000011.md) | [8.6](/filings/0000714395-26-000027.md) | [9.9](/filings/0000714395-26-000032.md) |
| Net income | $m | [21.5](/filings/0000714395-24-000054.md) | [21.5 d](/filings/0000714395-26-000011.md) | [19.0](/filings/0000714395-25-000053.md) | [20.5](/filings/0000714395-25-000053.md) | [21.0](/filings/0000714395-25-000053.md) | [23.2 d](/filings/0000714395-26-000011.md) | [10.5](/filings/0000714395-26-000032.md) | [31.4](/filings/0000714395-26-000032.md) | [35.1](/filings/0000714395-25-000053.md) | [35.7 d](/filings/0000714395-26-000011.md) | [33.2](/filings/0000714395-26-000032.md) | [38.2](/filings/0000714395-26-000032.md) |
| Diluted EPS | $ per share | [0.73](/filings/0000714395-24-000054.md) | not reported | [0.64](/filings/0000714395-25-000021.md) | [0.69](/filings/0000714395-25-000031.md) | [0.71](/filings/0000714395-25-000053.md) | not reported | [0.30](/filings/0000714395-26-000027.md) | [0.84](/filings/0000714395-26-000032.md) | [0.94](/filings/0000714395-25-000053.md) | not reported | [0.88](/filings/0000714395-26-000027.md) | [1.02](/filings/0000714395-26-000032.md) |
| Basic EPS | $ per share | [0.73](/filings/0000714395-24-000054.md) | not reported | [0.64](/filings/0000714395-25-000021.md) | [0.69](/filings/0000714395-25-000031.md) | [0.71](/filings/0000714395-25-000053.md) | not reported | [0.30](/filings/0000714395-26-000027.md) | [0.84](/filings/0000714395-26-000032.md) | [0.94](/filings/0000714395-25-000053.md) | not reported | [0.88](/filings/0000714395-26-000027.md) | [1.02](/filings/0000714395-26-000032.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [6,006](/filings/0000714395-23-000055.md) | [6,152](/filings/0000714395-26-000011.md) | [6,112](/filings/0000714395-24-000028.md) | [6,217](/filings/0000714395-24-000036.md) | [6,261](/filings/0000714395-24-000054.md) | [6,296](/filings/0000714395-26-000011.md) | [8,420](/filings/0000714395-25-000021.md) | [8,280](/filings/0000714395-25-000031.md) | [8,401](/filings/0000714395-25-000053.md) | [8,389](/filings/0000714395-26-000032.md) | [8,382](/filings/0000714395-26-000027.md) | [8,440](/filings/0000714395-26-000032.md) |
| Total liabilities | $m | [5,467](/filings/0000714395-23-000055.md) | [5,489](/filings/0000714395-25-000012.md) | [5,457](/filings/0000714395-24-000028.md) | [5,529](/filings/0000714395-24-000036.md) | [5,516](/filings/0000714395-24-000054.md) | [5,581](/filings/0000714395-26-000011.md) | [7,374](/filings/0000714395-25-000021.md) | [7,211](/filings/0000714395-25-000031.md) | [7,282](/filings/0000714395-25-000053.md) | [7,226](/filings/0000714395-26-000032.md) | [7,208](/filings/0000714395-26-000027.md) | [7,228](/filings/0000714395-26-000032.md) |
| Long-term debt | $m | not reported | [89.5](/filings/0000714395-24-000014.md) | not reported | not reported | not reported | [115](/filings/0000714395-25-000012.md) | not reported | not reported | not reported | [100](/filings/0000714395-26-000011.md) | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [538](/filings/0000714395-24-000054.md) | [664](/filings/0000714395-26-000011.md) | [655](/filings/0000714395-25-000053.md) | [688](/filings/0000714395-25-000053.md) | [745](/filings/0000714395-25-000053.md) | [715](/filings/0000714395-26-000032.md) | [1,046](/filings/0000714395-26-000032.md) | [1,070](/filings/0000714395-26-000032.md) | [1,120](/filings/0000714395-25-000053.md) | [1,162](/filings/0000714395-26-000032.md) | [1,175](/filings/0000714395-26-000032.md) | [1,212](/filings/0000714395-26-000032.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [24.4 d](/filings/0000714395-24-000054.md) | [29.6 d](/filings/0000714395-26-000011.md) | [23.9](/filings/0000714395-25-000021.md) | [18.7 d](/filings/0000714395-25-000031.md) | [24.5 d](/filings/0000714395-25-000053.md) | [28.7 d](/filings/0000714395-26-000011.md) | [37.9](/filings/0000714395-26-000027.md) | [26.9 d](/filings/0000714395-26-000032.md) | [51.8 d](/filings/0000714395-25-000053.md) | [42.7 d](/filings/0000714395-26-000011.md) | [37.0](/filings/0000714395-26-000027.md) | [58.1 d](/filings/0000714395-26-000032.md) |
| Capital expenditure | $m | [1.0 d](/filings/0000714395-24-000054.md) | [0.2 d](/filings/0000714395-26-000011.md) | [1.2](/filings/0000714395-25-000021.md) | [1.7 d](/filings/0000714395-25-000031.md) | [1.5 d](/filings/0000714395-25-000053.md) | [0.7 d](/filings/0000714395-26-000011.md) | [1.3](/filings/0000714395-26-000027.md) | [0.8 d](/filings/0000714395-26-000032.md) | [1.7 d](/filings/0000714395-25-000053.md) | [1.7 d](/filings/0000714395-26-000011.md) | [1.1](/filings/0000714395-26-000027.md) | [2.9 d](/filings/0000714395-26-000032.md) |
| Dividends paid | $m | [7.4 d](/filings/0000714395-24-000054.md) | [7.4 d](/filings/0000714395-26-000011.md) | [8.0](/filings/0000714395-25-000021.md) | [8.0 d](/filings/0000714395-25-000031.md) | [8.0 d](/filings/0000714395-25-000053.md) | [8.0 d](/filings/0000714395-26-000011.md) | [10.8](/filings/0000714395-26-000027.md) | [10.8 d](/filings/0000714395-26-000032.md) | [10.8 d](/filings/0000714395-25-000053.md) | [10.8 d](/filings/0000714395-26-000011.md) | [11.6](/filings/0000714395-26-000027.md) | [11.6 d](/filings/0000714395-26-000032.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [29.5](/filings/0000714395-23-000055.md) | [29.5](/filings/0000714395-24-000028.md) | [29.6](/filings/0000714395-24-000036.md) | [29.6](/filings/0000714395-24-000054.md) | [29.6](/filings/0000714395-25-000021.md) | [29.7](/filings/0000714395-25-000031.md) | [29.7](/filings/0000714395-25-000053.md) | [34.7](/filings/0000714395-26-000027.md) | [37.5](/filings/0000714395-26-000032.md) | [37.5](/filings/0000714395-25-000053.md) | [37.5](/filings/0000714395-26-000027.md) | [37.6](/filings/0000714395-26-000032.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 37,578,808 at 2026-08-01, from the cover of the [10-Q filed 2026-08-06](/filings/0000714395-26-000032.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.